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Improving aneurysm-related outcomes:
Nationwide benefits of endovascular repair
Ellen D. Dillavou, MD,a Satish C. Muluk, MD,b and Michel S. Makaroun, MD,a Pittsburgh, Penn
Objectives: Endovascular aneurysm repair (EVAR) has changed the practice of abdominal aortic aneurysm (AAA) surgery.
We examined a national Medicare database to establish the effect of EVAR introduction into the United States.
Methods: A 5% random sample of inpatient Medicare claims from 2000 to 2003 was queried using International
Classification of Diseases, 9th Revision (ICD-9) diagnosis and procedure codes. An EVAR procedure code was available
after October 2000. Occurrences were multiplied by 20 to estimate yearly national volumes and then divided into the
yearly Centers for Medicare and Medicaid Services (CMS) population of elderly Medicare recipients for rates per capita,
reported as cases per 100,000 elderly Medicare recipients. Statistical analysis was performed by using 2, Student’s t test,
nonparametric tests, and multiple regression analysis, with significance defined as P < .05.
Results: Elective AAA repairs averaged 87.7 per 100,000 Medicare patients between 2000 and 2003, with EVAR has
steadily increasing to 41% of elective repairs in 2003. From 2000 to 2003, overall elective AAA mortality declined from
5.0% to 3.7% (P < .001), while open repair mortality remained unchanged. EVAR patients are significantly older than
patients treated with open repair. From 2000 to 2003 patients>84 years receiving EVAR increased to 62.7% (P< .001).
Overall hospital length of stay (LOS) decreased from 8.6 days in 2000 to 7.3 days in 2003, P < .001, but increased for
open AAA patients. EVAR patients were more likely to be discharged home rather than to skilled facilities. Average
elective repair hospital charges were not different between groups, but Medicare reimbursement was lower for EVAR,
with a higher proportion cases classified as DRG111 (major cardiovascular procedure without complications). EVARwas
used in 10.6% of ruptured AAA repairs in 2003, with a significant reduction in mortality compared with open repairs for
rupture (31.8% vs 50.8%; P < .001).
Conclusions: EVAR is replacing open surgery without an increase in overall case volume. EVAR is responsible for overall
decrease in operative mortality even in ruptured aneurysms while decreasing utilization variables. Reimbursement to
hospitals is shrinking, however. ( J Vasc Surg 2006;43:446-52.)Endovascular aneurysm repair (EVAR) has changed
the practice of abdominal aortic aneurysm (AAA) surgery
over the past decade. EVAR 1 and Dutch Randomised
Endovascular Aneurysm Management (DREAM) trials of
Europe have established the early mortality advantage for
endovascular vs open repair1,2 and shown that there is a
persistent reduction in aneurysm-related death in EVAR
patients at 4 years.3
Although there have been excellent reports of EVAR’s
effects on academic practice4,5 and in individual states,6,7
there have been few reports of nationwide changes in the
United States. Early predictions forecasted an increase in AAA
surgery with the advent of EVAR, but the true effects of this
procedure on the volume of AAA repairs have still not been
described. This report examines nationwide trends in AAA
repair during the era of EVAR by looking at elderly Medicare
patients in a random sample of inpatient claims.
METHODS
Study aims and methodology were approved by the
University of Pittsburgh Institutional Review Board and by
the Centers for Medicare and Medicaid Services (CMS).
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446Data files were obtained from CMS and consisted of a
random sampling of 5% of inpatientMedicare claims during
a fiscal year, packaged as a 5% Beneficiary Encrypted File
(5% BEF). The sample is determined from random selec-
tion based on the digits at positions 8 and 9 of the health
insurance claim (HIC) number. This population sample
consisted of elderly Medicare patients who were not en-
rolled in health-care maintenance organizations (HMOs).
The number enrolled in HMOs varied from 7.4% to 17.0%
during the years 1994 to 2003 and has been previously
described.8 Data were obtained from CMS on CD-ROM in
text format. The 5% BEF files were purchased for years
1994 through 2001, and a similar sampling with increased
encryption to protect patient identity was purchased for
2002 and 2003 as a 5% Limited Data Set (LDS). Informa-
tion contained in the database included but was not limited
to patient demographic information, diagnostic and proce-
dure codes, discharge status, payment information, and
location of treatment. Data from 16,124 records were
analyzed, representing an estimated 322,480 patients with
an AAA diagnosis and procedure.
Files were translated into Microsoft Access (Redmond,
Wash) using a custom program written by one of the
authors (S. C. M). This program was validated against
results obtained from translation programs obtained from
CMS. Files were searched using final hospitalization Inter-
national Classification of Diseases, 9th Revision (ICD-9)
diagnosis codes 441.3 (ruptured AAA) or 441.4 (elective
AAA), and ICD-9 primary procedure codes 38.34 (aorta
resection and anastomosis), 38.36 (abdominal vessel resec-
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with replacement), 38.64 (excision of aorta), 39.25 (aorta
to iliac or femoral bypass), or 39.52 (aneurysm repair NEC)
for open repair. After October 2000, procedure code 39.71
(endovascular AAA repair) was available and used for
EVAR.
In the CMS data files, patients were divided into groups
by age:65 years, 65 to 69 years, 70 to 74 years, 75 to 79
years, 80 to 84 years, and 84 years. To calculate average
age, the median value for each range was used as a repre-
sentative: 62 was used for the first group and 87 for the last
group.
Discharge data were grouped into the four disposition
categories of discharge to home, transfer to short-term care
facility, transfer to long-term care facility, or death. Esti-
mates of death should be viewed as deaths occurring during
the hospital stay in question. Hospital charges and Medi-
care reimbursement are listed as they were reported in the
Medicare database.
Raw numbers of patients obtained from the 5% files
were multiplied by 20 to estimate yearly nationwide totals.
Estimates were then divided into population totals of el-
derly Medicare recipients minus HMO enrollees, all ob-
tained from CMS for each particular calendar year.
Statistical analysis was performed by comparing yearly
totals and comparing groups over time. The 2 test was
used to compare nominal variables, and the two-tailed
Student’s t test was used for comparing continuous vari-
ables after a binomial distribution had been verified. Mann-
Whitney and Wilcoxon rank sum tests were used for non-
parametric data. Logistic regression was used to perform
multivariate analysis, with a Hosmer-Lemeshow goodness
of fit statistic to ensure appropriate modeling. Significance
was defined as P  .05.
RESULTS
Surgical volume. The estimated total number of elec-
tive AAA repairs for elderly Medicare patients has not
changed significantly during the era of endovascular repair
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Fig 1. Elective abdominal aortic aneurysm (AAA) repairs, nor-
malized for population, 1994 to 2003. EVAR, endovascular an-
eurysm repair.(Fig 1). When normalized for population changes, theelective AAA repair rate per 100,000 Medicare recipients
declined from 98.9/100,000 in 2000 to 87.7/100,000 in
2003. During this time the elderly Medicare population
increased by nearly 750,000. Froom 2001 to 2003, the
percentage of patients who underwent elective endovascu-
lar repair significantly increased each year, with endovascu-
lar repair accounting for 31.2% of elective AAA surgery in
2001, 36.15% in 2002, and 41.4% in 2003 (P  .05 for
volume differences between each year).
EVAR for rupture was a rare but growing subset of
AAA repairs from 2000 to 2003. In 2001, 5.4% of ruptured
AAA patients received EVAR. By 2003, this had increased
to 10.6%.
Demographics. From 2001 to 2003, patients under-
going elective EVAR were older on average (75.1 vs 74.0
years, P .01) and more likely to be male (83.8% vs 76.1%,
P  .001) than patients having elective open repair. No
racial differences were seen (Table I). The patients most
likely to receive elective EVAR repair were the most elderly,
with dramatically more patients 84 years old receiving
EVAR vs their younger cohorts (Fig 2). In 2003, 21.0% of
all elective AAA repair patients were 80 years old, and
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Fig 2. Percentage of elective abdominal aortic aneurysm (AAA)
repair patients with endovascular aneurysm repair (EVAR), 2001
to 2003, by age group.
Table I. Demographics of elective open and
endovascular abdominal aortic aneurysm repair 2000
to 2003
2000 2001 2002 2003
Open repair
Number of repairs 26,320 19,360 18,720 16,100
Repairs per 100,000 93.48 66.92 63.04 52.90
Mean age 74.3 73.9 74.2 73.9
Percent male 76.7 75.7 77.9 74.9
Percent white 95.7 94.3 94.0 94.8
Endovascular repair
Number of repairs 1680 8760 10,700 11,380
Repairs per 100,000 5.97 30.28 36.03 37.39
Mean age 75.4 75.2* 75.2* 75.0*
Percent male 79.0* 82.7* 83.0* 85.9*
Percent white 100 94.4 95.0 94.5
*P  .05 open vs endovascular repair.47% of these had an EVAR repair; this rose to 62.7% of
JOURNAL OF VASCULAR SURGERY
March 2006448 Dillavou, Muluk, and Makarounpatients 84 years. Comparatively, 39.4% of patients 80
years underwent EVAR (P  .001 vs patients 80 years).
Mortality. Operative results varied between EVAR
and open AAA populations (Table II). From 2001 to 2003,
the average elective in-hospital mortality for EVAR was
1.9% vs 5.2% for open repair (P  .001) (Fig 3). Logistic
regression analysis revealed that endovascular repair, male
sex, and age 80 were predictive of survival (Table III).
Mortality rates in the most elderly patients were expect-
edly higher than for younger patients. For all elective AAA
repairs in 2003, the mortality rate was 6.4% for those 80
years vs 2.3% in patients 80 years (P  .001). EVAR
mortality was significantly less than open mortality in the
most elderly, however. Patients 84 years had an open
mortality of 16.1% vs 1.9% for EVAR (P  .001). Cumu-
lative mortality comparisons in 2001 to 2003 demon-
strated a significantly lower mortality for EVAR vs open
repair for all age groups, with the most pronounced differ-
ences in patients 84 years (Fig 3).
Ruptured AAA patients were increasingly treated with
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Fig 3. Cumulative operative mortality between 2001 and 2003
for elective open and endovascular aneurysm (EVAR) repair by
age groups. Difference in mortality of EVAR vs open, P .001 for
all age groups in univariate analysis.
Table II. Results of elective open and endovascular abdom
2000
All AAA repairs
Blood transfusion/patient (pints) .46
Length of stay (days) 8.55
Discharged to home (%) 80.6
Open repair
Blood transfusion/patient (pints) .48 (4.3)
Length of stay (days) 8.8 (9.3)
Discharged to home (%) 79.9
Endovascular repair
Blood transfusion/patient (pints) .27 (1.4)
Length of stay (days) 4.03 (3.9)*
Discharged to home (%) 91.4*
AAA, Abdominal aortic aneurysm.
Standard deviation is shown in parentheses where appropriate.
*P  .05 for open vs endovascular aneurysm repair.EVAR. In 2003, 10.6% of ruptures were treated endovas-cularly. Mortality rates for this small number of patients
were significantly lower than for open repair. Rupture
mortality for open repair was 51.98% vs 33.33% for EVAR
in 2003, 50.27% vs 30.77% for 2002, and 47.43% vs 20.0%
for 2001, respectively (P  .001 for each year).
Discharge and payment. From 2000 to 2003, length
of stay was lower for elective EVAR (9.6 vs 3.8 days, P 
.001), and the percentage of patients discharged to home
was higher (91.2% vs 77.7%, P  .001) (see Table II). From
2000 to 2003, hospital charges for elective repair were not
significantly different between open repairs and EVAR (aver-
age $55,084 vs $56,936, P  NS), although Medicare
reimbursements were lower for EVAR ($19,724 vs
$22,248, P  .002). When individual years are examined,
the average charges between EVAR and open repairs do
not appear discrepant, but the median charges are higher
for EVAR (see Table IV). This reached significance in 2001
and 2002. The difference between median hospital charges
vs Medicare payment was significantly greater for EVAR vs
open repairs for 2001, 2002, and 2003. The percentage of
aortic aneurysm repair, 2000 to 2003
2001 2002 2003
.53 .36 .39
7.84 7.34 7.34
82.8 83.4 81.7
.69 (7.6) .49 (3.1) .52 (3.8)
9.52 (9.1) 9.52 (8.6) 9.83 (9.3)
79.2% 78.5% 75.4%
.15 (1.0)* .12 (1.3)* .20 (1.3)
4.12 (6.2)* 3.47 (4.1)* 3.77 (5.2)*
90.7* 92.2* 90.9*
Table III. Logistic regression analysis of variables
affecting mortality after elective abdominal aortic
aneurysm repair, 2000-2003
Factor OR 95% CI P
Endovascular repair 0.34 0.22-0.50 .001
Age (vs 65 years)
65-69 years 0.71 0.30-1.66 .43
70-74 years 1.02 0.45-2.27 .97
75-79 years 1.47 0.66-3.24 .34
80-84 years 2 0.89-4.47 .09
84 years 2.79 1.16-6.68 .02
Male 0.63 0.47-0.84 .004
Year of surgery (vs 2003)
2000 1.04 0.71-1.52 .85
2001 1.02 0.68-1.51 .93
2002 1.12 0.76-1.65 .55
OR, Odds ratio; CI, confidence interval.inalpatients who were coded under DRG 111 (major cardio-
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EVAR patients than for those with open repair (33.3% vs
17.2%, P  .001).
DISCUSSION
Endovascular repair currently comprises more than 40%
of all elective AAA repairs, with the percentage increasing
significantly each for the last 3 years. These increases have
been in the face of no overall volume changes and an actual
decrease in repairs per capita. The effects of EVAR on the
total AAA repair population were evident in trends from the
year 2000 to 2003: a decrease in overall mortality from
5.03% to 3.67%, a decrease in hospital length of stay from
8.55 to 7.34 days, and a decrease in the percentage of
patients being discharged to nursing facilities. The de-
creases in these variables were in the face of increasing
values in open AAA patients, with open AAA surgery still
accounting for most operations each year.
The differences in mortality between open and EVAR
repairs were not demonstrated in trials for individual en-
dografts,9-11 but larger series including randomized trials1-3
and comparisons using administrative databases12 have re-
cently shown that EVAR has a mortality advantage in the
postoperative period. Our large, nationwide review dem-
onstrates a clear EVAR advantage in perioperative mortality
rates. This advantage was most pronounced in the most
elderly patients. Those 84 years were significantly more
likely than other age groups to have EVAR, and these
patients had much lower mortality for EVAR than for open
repairs. The dramatic increases in mortality with age for
open repairs were not mirrored in the EVAR population,
illustrating that EVAR is the preferred option for the most
elderly patients if anatomically feasible.
Women also have a decreased mortality for EVAR vs
open repair, but EVARmortality rates have been previously
found to be significantly higher in women than in men.6,8
Sex, along with age and endovascular repair, was found to
be an independent predictor of mortality after elective AAA
surgery in these analyses. Although the definitive causes
Table IV. Hospital charges and Medicare payment data fo
2000
Open AAA repair
Hospital charges—average $47,000 (54,595)
Hospital charges—median $34,096
Medicare payment—average $20,667 (17,778)
Medicare payment—median $17,940
Median payment minus charges $16,157
Endovascular repair
Hospital charges—average $45,060 (18,773)
Hospital charges—median $42,488
Medicare payment—average $17,345 (6627)
Medicare payment—median $17,749
Median payment minus charges $24,739
AAA, Abdominal aortic aneurysm.
Standard deviation is shown in parentheses where appropriate.
*P  .05 for open vs endovascular aneurysm repair.of the increased mortality in women have yet to be eluci-dated, poorer outcomes in women have been clearly estab-
lished. Interestingly, phase II trials with stringent anatomic
entrance criteria have not shown a worse outcome for
women.11 This points to anatomy as a major factor in
disparate results between the genders, with anatomic dif-
ferences having been previously described.13,14
The advantage of EVAR in rupture patients is not
unexpected, but must be considered in the light that the
open and EVAR rupture groups may have had very differ-
ent clinical presentations, with a possibility that only the
most stable patients were evaluated for EVAR. Unfortu-
nately, the Medicare data are not detailed enough to make
this assessment. Regardless, the increase in the numbers of
EVAR repairs with a diagnosis of AAA rupture shows that
this method of AAA repair has become a routine tool in the
battle against aneurysm disease.
Our data demonstrated a financial advantage to open vs
endovascular repair. The average elective hospital charges
were not widely disparate, but the median charges for
EVAR were much higher than for open repair, in part
reflecting the large number of open repair patients with
complications and higher hospital expenditure. Medicare
reimbursements were also consistently lower for EVAR,
which led to a significantly larger gap between hospital
charges and reimbursements for EVAR vs open patients.
Lower reimbursements are probably secondary to more
EVARs done under the DRG 111 code (major cardiovas-
cular procedure without complications). Although EVAR
patients were significantly older and in previous studies
have been demonstrated to have equal or more comorbidi-
ties than their open counterparts,5,11,12,15 the lack of post-
operative complications or coding oversights have contrib-
uted to a higher percentage of EVARs as DRG 111.
The assets and limitations of the Medicare database
deserve discussion. This is an administrative database that
we have used to assess clinical outcomes. Although there
are known problems with the use of administrative data-
bases, coding errors, and a tendency to underestimate
procedures with the Medicare files,16 these errors should be
ctive open and endovascular aneurysm repair procedures
2001 2002 2003
549 (57,559) $56,485 (55,707) $63,773 (80,620)
35,159 $39,485 $43,324
653 (18,034) $22,239 (17,984) $22,854 (22,931)
18,796 $19,204 $19,826
16,363 $20,281 $23,497
560 (35,906) $52,863 (35,155) $61,829 (45,476)
42,437* $44,838* $51,894
647 (12,772) $19,869 (11,681) $19,656* (10,650)
18,188 $18,838 $18,922
24,249* $25,999* $32,971*r ele
$50,
$
$21,
$
$
$50,
$
$19,
$
$consistent. Since CMS did not have a code for endovascular
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assessment of EVAR use or results before this time. Un-
doubtedly, endovascular repairs were performed in the late
1990s and early in the year 2000 that were billed as open
AAA repair or otherwise miscoded. For this reason, all
comparisons did not start with the year 2000.
We are confidant, however, that the procedures coded
as endovascular repairs were true EVARs. To meet our
search criteria, each case had to have both an appropriate
diagnosis and procedure code, and the accuracy of the use
of ICD-9 codes in administrative databases has been vali-
dated.17 There are certain to be patients missed with this
strategy, both open and EVAR, but these margins should
be consistent. It is also possible that a small number of
patients underwent conversion from EVAR to open, and it
is unknown how these would have been coded.
Despite the above considerations, there is great value in
the Medicare data. This is a mandatory reporting of data
regardless of hospital size or academic affiliation. The Na-
tional Inpatient Sample (NIS) was used in 2001 to report
on EVAR vs open repair,12 but these are voluntarily sub-
mitted data from selected states. The National Hospital
Discharge Survey (NHDS) is also voluntarily and, like the
NIS, does not include federal facilities. The National Sur-
gical Quality Improvement Program (NSQIP) is the Vet-
eran’s Administration database, and the private sector ex-
tension (NSQIP-PS) is a group of 14 academic hospitals
that have used this database to compare EVAR and open
AAA repair.5 None of these databases include all hospital
types or a nationwide sample to gather information. Also,
unlike smaller, more selective databases there is virtually no
chance for sampling errors with the Medicare database. As
a sample based on the last digits of the HIC number, there
is no geographic, racial, sex, or other bias possible.
Approximately 75% to 85% of AAA repairs each year18
are covered by Medicare. This percentage has not changed
significantly from 1997 to 2003.18 As there my be up to
25% of patients who have AAA repair and are not covered in
this Medicare database,18 the estimates of total yearly sur-
gical volume are not exact. The percentage of patients with
Medicare has not significantly changed, however, so we can
be confident that the trends seen here are accurate.
Errors in coding are part of any administrative database,
but these, too, should be stable over time. The possibility of
these errors should not detract from the large volumes of
information gleaned from the database.
There is undoubtedly a difference in the complexity of
open AAA repair in 2003 compared with a typical open repair
before the endovascular era. An increasing percentage of
open repairs are juxtarenal and suprarenal aneurysms,4 and
women are more often have open rather than endovascular
repairs.5,8,11 Conversely, EVAR patients are more likely to
be older and with more comorbidities.5,11,12,15 These facts
point to two dissimilar populations undergoing infrarenal
AAA repair. For that reason, a retrospective analysis of
results between the two groups is less of a direct compari-
son and more a report of results. Prospective studies of
matched patients such as in the EVAR 1,2,3 DREAM1 andVeterans Affairs Open Vs Endovascular Repair (OVER)
trials are a much better means to directly compare EVAR
and open results, both immediately and long term. How-
ever, what theMedicare database has illustrated is the effect
of EVAR alone and on the results of AAA repairs in general.
CONCLUSIONS
Endovascular AAA repair constitutes an increasing pro-
portion of elective and emergent AAA surgery. The results
for EVAR are excellent, with2%mortality in a nationwide
sample. The outstanding perioperative results for EVAR
have influenced AAA repair outcomes overall with de-
creases in length of stay, decreases in mortality, and a larger
number of patients discharged to home. The gap between
EVAR costs and reimbursements is widening, however.
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Dr K. Craig Kent (New York, NY). As you know, this is an
area that I have been interested in for a number of years. One of the
issues is with the coding. I am concerned that in the coding that
you have used, that for the open repairs you are dealing with
anatomic configurations that are different than those patients who
received endovascular repair, specifically, there are probably a fair
number of patients in the open group that have pararenal aneu-
rysms or complex iliac disease. And if that is in fact true, youmay be
comparing apples to oranges. It may be that the group of patients
who had open repair are more difficult patients to treat and might,
by design, have a less favorable outcome. Is that a possibility, or do
you think that the coding is able to select those patients out?
Dr Ellen D. Dillavou. I think your point is excellent, and that
is definitely a possibility. The codes we used were for infrarenal
repairs, but there is a possibility that some more complicated
repairs are included.
Part of the background of this study is we have looked at
repairs for 1994 through 2003 as well, and we have not found a
significant difference in pre-endovascular repair results vs post in
looking at open repairs. And so the population does not seem to
have been significantly changed for the worse since endovascular
repairs. To say that all good anatomy patients are being treated by
endovascular repair now, I think would be a stretch, since the open
surgical results have been pretty consistent over the last decade.
Dr Jihad Abbas (Toledo, Ohio). Other than the cost of
money, what is the cost of doing more endovascular repair on
training fellows and subsequently increasing mortalities on open
repairs, especially ruptured ones?
Dr Dillavou. If I understand your question, you are asking
what impact increased endovascular repairs have had on our train-
ing?
Dr Abbas. On the training for open repair. Subsequent
fellows will be less trained on open repair, you will have less
experienced surgeons fixing open aneurysms, especially ruptured
ones.
Dr Dillavou. Unfortunately, this database, ending in 2003,
does not get to the population of surgeons that have been trained
doing more endovascular than open repairs. So I don’t think our
data can reflect that, but that is certainly a concern.
Dr Jon Matsumura (Chicago, Ill). Outcomes with open
repair have been correlated with procedural volume and vascular
certificates. Can you tell us if you have looked at correlates with
outcomes and procedural volume with the endovascular repair?
We also want to know about device-specific outcomes. Do you
have the CPT codes, and have you looked at device comparisons in
this database?
Dr Dillavou. Unfortunately, we are not able to compare
devices through this database. That sort of specific information just
is not available. Similarly, procedural volume and outcome corre-Dr Darwin Eton (Miami, Fla). First, the anatomic and phys-
iologic characteristics of patients undergoing surgery are evolving
since the introduction of the aortic endograft. Can you comment
on the outcome data essentially remaining constant during the
study interval?
Second, as the better anatomy is selected out for endograft
placement, a more challenging anatomy remains in the surgery
group. Can one still compare the endograft and surgery groups,
since the populations are no longer the same (the more favorable
anatomy being treated endovascularly)?
Third, your study is focused on the mortality and outcome
within the perioperative period, but the issue of efficacy still
remains. For instance, the ADAM study showed surgery is safe for
small aneurysms, but also showed no change in life expectancy
between the treated and observed groups.Will you be reporting on
efficacy in the future? This will help us identify if there is merit to
treating an AAA sooner when the anatomy is endovascularly more
favorable, since two thirds of patients in the ADAM trial lived long
enough to have a AAA exceeding the 5.5-cm threshold.
Fourth, as safety of the endovascular devices improves, efficacy
is becoming the key issue. The natural history of smaller aneurysms
is less severe than previously thought (annual rupture rate for 4.0-
to 5.4-cm AAAs reported in the ADAM and UKSAT trials ranged
between 0.6% and 1.0%). A large number of enrollees will be
needed to show statistical benefit on the efficacy issue.
Dr Dillavou. I think those are excellent points. And studies
like the DREAM trial and the OVER trial should, I think, be
able to tell us better about the overall efficacy over time. Because
you are right, our database here is very focused on 30-day
mortality.
DrEton. Yes. In your statistics, the way you are presenting the
data over time, as the endovascular group is going up in volume,
the patient selection is now changing, favoring that group and not
favoring the surgical group, but the mortality for the surgical
group stayed fairly constant.
Dr Dillavou. I think there are probably two explanations for
your first point about difficult anatomy and outcomes. One, the
number of perivisceral and renal involvement aneurysms is a small
subset of the whole, so I think that even with open repair, the
majority of repairs are probably still strictly infrarenal.
Second, even with more complex aneurysms, I think that as
the mortality for those repairs increases slightly, our advances in
critical care and other operative techniques are also advancing. So
those two trends balance each other out, giving us a more stable,
open mortality over the last few years.
Dr Kent.When we began to look at this data, our hypothesis
was that, with the less invasive and less mortal way of repairing
aneurysms, the volume of aneurysm repairs would increase. We
were relatively certain this would be a side effect of endovascular
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is the case?
Dr Dillavou. That was our hypothesis to start as well. And
we expected to see a spike in aneurysm repairs starting in 1999
and steadily increasing from there. I believe there are a couple
explanations, but it probably gets back to screening and the
fact that we still have a large population of aneurysm pa-tients that are undetected. Initially, we saw a small increase in
repairs per capita in 1999 and 2000, which may have been
patients that were thought to be too morbid for open repair,
who then got an endovascular repair. But since then it has pretty
much leveled out. This probably goes back to screening and the
need to increase our own vigilance and that of primary care
providers.
